Correction to: Safety and efficacy of nivolumab in combination with sunitinib or pazopanib in advanced or metastatic renal cell carcinoma: the CheckMate 016 study

Overview of attention for article published in Journal for Immunotherapy of Cancer, March 2019

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (95th percentile)
High Attention Score compared to outputs of the same age and source (92nd percentile)

So far, Dimensions has found 7 publications that cite this research output.

Article in Aging (April 2024)

Article in Biochemical Genetics (May 2022)

Article in International braz j urol (December 2021)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.